SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000939767-23-000047
Filing Date
2023-05-09
Accepted
2023-05-09 16:13:14
Documents
15
Period of Report
2023-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exel-20230509.htm   iXBRL 8-K 35140
2 EX-99.1 exel20230331exhibit991.htm EX-99.1 122329
6 exel-20230509_g1.jpg GRAPHIC 55431
7 exelixis_logoxrgbx2023.jpg GRAPHIC 55431
  Complete submission text file 0000939767-23-000047.txt   519985

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20230509.xsd EX-101.SCH 1915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20230509_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20230509_pre.xml EX-101.PRE 12520
9 EXTRACTED XBRL INSTANCE DOCUMENT exel-20230509_htm.xml XML 10707
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

IRS No.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30235 | Film No.: 23902153
SIC: 2836 Biological Products, (No Diagnostic Substances)